International Journal of Hematology

, Volume 109, Issue 2, pp 187–196 | Cite as

Hematopoietic stem cell transplantation for subcutaneous panniculitis-like T-cell lymphoma: single center experience in an Asian population

  • Ting-An Lin
  • Ching-Fen Yang
  • Yao-Chung Liu
  • Jin-Hwang Liu
  • Tzeon-jye Chiou
  • Liang-Tsai Hsiao
  • Hsiu-Ju Yen
  • Chia-Jen Liu
  • Hao-Yuan Wang
  • Po-Shen Ko
  • Sheng-Hsuan Chien
  • Jyh-Pyng GauEmail author
Original Article


Subcutaneous panniculitis-like T-cell lymphoma (SPTL) is a rare form of cytotoxic T-cell lymphoma. It is believed that SPTL in patients without hemophagocytic syndrome (HPS) follows an indolent course; in contrast, SPTL in patients with HPS has been associated with unfavorable survival. To provide more clinical data on SPTL in Asian populations and to identify optimal therapeutic strategies for SPTL, we assessed the clinicopathological features and long-term follow-up data of 10 Taiwanese SPTL patients diagnosed at a single center. Our study demonstrates a group of patients with high incidence of HPS (50%), rather aggressive courses, and early progression. A total of eight patients underwent hematopoietic stem cell transplant (HSCT), including one autologous HSCT and seven allogeneic HSCT. Seven of eight patients receiving HSCT achieved durable remission and maintained in remission for over 30 months (range 30–132 months). There was no difference in 3-year survival of patients with HPS (80%) compared with patients without HPS (80%). Of long-term survivors in the HPS group, three of four received HSCT (autologous HSCT, n = 1; allogeneic HSCT, n = 2). Our study indicated that HSCT is a curative option for eligible SPTL patients with HPS.


Subcutaneous panniculitis-like T-cell lymphoma Hemophagocytic syndrome Stem cell transplantation Allogeneic Chemotherapy 



This work was partially supported by grants from Taipei Veterans General Hospital (V107C-192, VGHUST107-G3-1-2) and Chong Hin Loon Memorial Cancer and Biotherapy Research Cancer, National Yang-Ming University. The funding sources had no role in the study design or conduct, or in the decision to submit it for publication.

Author contributions

TAL coordinated the study, performed the statistical analysis, and wrote the paper; JPG designed the study, interpreted data and critically revised the manuscript; C.F.Y reviewed histopathology findings and performed immunohistochemical stains; all authors: collected clinical, laboratory, and histology data. All authors gave final approval to the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interests.


  1. 1.
    Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol. 1991;15(1):17–27.CrossRefGoogle Scholar
  2. 2.
    Jaffe ES. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.Google Scholar
  3. 3.
    Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol. 1998;22(7):881–93.CrossRefGoogle Scholar
  4. 4.
    Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. 2003;148(3):516–25.CrossRefGoogle Scholar
  5. 5.
    Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer. 2004;101(6):1404–13.CrossRefGoogle Scholar
  6. 6.
    Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–85.CrossRefGoogle Scholar
  7. 7.
    Swerlow SH, World Health O. WHO classification of tumours of haematopoietic and lymphoid tissues: WHO; 2008.Google Scholar
  8. 8.
    Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838–45.CrossRefGoogle Scholar
  9. 9.
    Lee DW, Yang JH, Lee SM, Won CH, Chang S, Lee MW, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 korean patients. Ann Dermatol. 2011;23(3):329–37.CrossRefGoogle Scholar
  10. 10.
    Oschlies I, Simonitsch-Klupp I, Maldyk J, Konovalov D, Abramov D, Myakova N, et al. Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome. Br J Dermatol. 2015;172(3):793–7.CrossRefGoogle Scholar
  11. 11.
    Jang MS, Baek JW, Kang DY, Kang JS, Suh KS, Kim ST. Subcutaneous panniculitis-like T-cell lymphoma: successful treatment with systemic steroid alone. J Dermatol. 2012;39(1):96–9.CrossRefGoogle Scholar
  12. 12.
    Briki H, Bouaziz JD, Molinier-Frenkel V, Delfau-Larue MH, Ortonne N, Bagot M. Subcutaneous panniculitis-like T-cell lymphoma alphabeta: complete sustained remission with corticosteroids and methotrexate. Br J Dermatol. 2010;163(5):1136–8.CrossRefGoogle Scholar
  13. 13.
    Tsukamoto Y, Katsunobu Y, Omura Y, Maeda I, Hirai M, Teshima H, et al. Subcutaneous panniculitis-like T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A. Intern Med. 2006;45(1):21–4.CrossRefGoogle Scholar
  14. 14.
    Lee WS, Hwang JH, Kim MJ, Go SI, Lee A, Song HN, et al. Cyclosporine A as a primary treatment for panniculitis-like T cell lymphoma: a case with a long-term remission. Cancer Res Treat. 2014;46(3):312–6.CrossRefGoogle Scholar
  15. 15.
    Michonneau D, Petrella T, Ortonne N, Ingen-Housz-Oro S, Franck N, Barete S, et al. Subcutaneous panniculitis-like T-cell lymphoma: immunosuppressive drugs induce better response than polychemotherapy. Acta Derm Venereol. 2017;97(3):358–64.CrossRefGoogle Scholar
  16. 16.
    Ghobrial IM, Weenig RH, Pittlekow MR, Qu G, Kurtin PJ, Ristow K, et al. Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma. 2005;46(5):703–8.CrossRefGoogle Scholar
  17. 17.
    Ohtsuka M, Miura T, Yamamoto T. Clinical characteristics, differential diagnosis, and treatment outcome of subcutaneous panniculitis-like T-cell lymphoma: a literature review of published Japanese cases. Eur J Dermatol. 2017;27(1):34–41.Google Scholar
  18. 18.
    Koh MJ, Sadarangani SP, Chan YC, Chan MY, Tan AM, Tan SH, et al. Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma). J Am Acad Dermatol. 2009;61(5):875–81.CrossRefGoogle Scholar
  19. 19.
    Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma: an elusive case presenting as lipomembranous panniculitis and a review of 72 cases in the literature. Am J Dermatopathol. 2001;23(3):206–15.CrossRefGoogle Scholar
  20. 20.
    Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRefGoogle Scholar
  21. 21.
    Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110(2):479–84.CrossRefGoogle Scholar
  22. 22.
    Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579–86.CrossRefGoogle Scholar
  23. 23.
    Huppmann AR, Xi L, Raffeld M, Pittaluga S, Jaffe ES. Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential. Pediatr Blood Cancer. 2013;60(7):1165–70.CrossRefGoogle Scholar
  24. 24.
    Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32(10):1495–502.CrossRefGoogle Scholar
  25. 25.
    Sakurai E, Satoh T, Akiko YA, Maesawa C, Tsunoda K, Endo M, et al. Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with hemophagocytosis (HPS): successful treatment using high-dose chemotherapy (BFM-NHL & ALL-90) and autologous peripheral blood stem cell transplantation. J Clin Exp Hematop. 2013;53(2):135–40.CrossRefGoogle Scholar
  26. 26.
    Medhi K, Kumar R, Rishi A, Kumar L, Bakhshi S. Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis: complete remission with BFM-90 protocol. J Pediatr Hematol Oncol. 2008;30(7):558–61.CrossRefGoogle Scholar
  27. 27.
    Gupta V, Arava S, Bakhshi S, Vashisht KR, Reddy R, Gupta S. Subcutaneous panniculitis-Like T-Cell lymphoma with hemophagocytic syndrome in a child. Pediatr Dermatol. 2016;33(2):e72-6.CrossRefGoogle Scholar
  28. 28.
    Mukai HY, Okoshi Y, Shimizu S, Katsura Y, Takei N, Hasegawa Y, et al. Successful treatment of a patient with subcutaneous panniculitis-like T-cell lymphoma with high-dose chemotherapy and total body irradiation. Eur J Haematol. 2003;70(6):413–6.CrossRefGoogle Scholar
  29. 29.
    Dholaria B, Patel RJ, Sluzevich JC, Ailawadhi S, Roy V. Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant. Ann Hematol. 2017;96(12):2125–6.CrossRefGoogle Scholar
  30. 30.
    Brown NA, Ross CW, Gudjonsson JE, Wale D, Pawarode A, Maillard I, et al. Subcutaneous panniculitis-like T-cell lymphoma with bone marrow involvement. Am J Clin Pathol. 2015;143(2):265–73.CrossRefGoogle Scholar
  31. 31.
    Gao J, Gauerke SJ, Martinez-Escala ME, Guitart J, Nelson BP, Chadburn A, et al. Bone marrow involvement by subcutaneous panniculitis-like T-cell lymphoma: a report of three cases. Mod Pathol. 2014;27(6):800–7.CrossRefGoogle Scholar
  32. 32.
    Yuan L, Sun L, Bo J, Zhou Y, Li HH, Yu L, et al. Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine. Ann Transplant. 2011;16(3):135–8.CrossRefGoogle Scholar
  33. 33.
    Ichii M, Hatanaka K, Imakita M, Ueda Y, Kishino B, Tamaki T. Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor. Leuk Lymphoma. 2006;47(10):2250–2.CrossRefGoogle Scholar
  34. 34.
    Yokota K, Akiyama Y, Adachi D, Shindo Y, Yoshida Y, Miyoshi F, et al. Subcutaneous panniculitis-like T-cell lymphoma accompanied by Sjogren’s syndrome. Scand J Rheumatol. 2009;38(6):494–5.CrossRefGoogle Scholar
  35. 35.
    Go SI, Lee WS, Kang MH, Kim IS, Kim DC, Lee JH. Cyclosporine A treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: a case with long-term follow-up. Korean J Hematol. 2012;47(2):146–9.CrossRefGoogle Scholar
  36. 36.
    Nagai K, Nakano N, Iwai T, Iwai A, Tauchi H, Ohshima K, et al. Pediatric subcutaneous panniculitis-like T-cell lymphoma with favorable result by immunosuppressive therapy: a report of two cases. Pediatr Hematol Oncol. 2014;31(6):528–33.CrossRefGoogle Scholar
  37. 37.
    Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M, Group EGW. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi149–54.CrossRefGoogle Scholar
  38. 38.
    Wasik F, Kolodziej T, Jelen M, Pejcz J. Subcutaneous T-cell lymphoma: report of two cases. J Eur Acad Dermatol Venereol. 1998;10(1):62–6.CrossRefGoogle Scholar
  39. 39.
    Rudolph N, Klemke CD, Ziemer M, Simon JC, Treudler R. Hemophagocytic lymphohistiocytosis associated with subcutaneous panniculitis-like T-cell lymphoma. J Dtsch Dermatol Ges. 2016;14(11):1140–2.CrossRefGoogle Scholar
  40. 40.
    Bader-Meunier B, Fraitag S, Janssen C, Brochard K, Lamant L, Wouters C, et al. Clonal cytophagic histiocytic panniculitis in children may be cured by cyclosporine A. Pediatrics. 2013;132(2):e545-9.CrossRefGoogle Scholar
  41. 41.
    Chen CC, Teng CL, Yeh SP. Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review. Ann Hematol. 2016;95(5):837–40.CrossRefGoogle Scholar
  42. 42.
    Al Zolibani AA, Al Robaee AA, Qureshi MG, Al Nosian H. Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A. Skinmed. 2006;5(4):195–7.CrossRefGoogle Scholar
  43. 43.
    Chen R, Liu L, Liang YM. Treatment relapsed subcutaneous panniculitis-like T-cell lymphoma together HPS by Cyclosporin A. Hematol Rep. 2010;2(1):e9.CrossRefGoogle Scholar
  44. 44.
    Rojnuckarin P, Nakorn TN, Assanasen T, Wannakrairot P, Intragumtornchai T. Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma. 2007;48(3):560–3.CrossRefGoogle Scholar
  45. 45.
    Mizutani S, Kuroda J, Shimura Y, Kobayashi T, Tsutsumi Y, Yamashita M, et al. Cyclosporine A for chemotherapy-resistant subcutaneous panniculitis-like T cell lymphoma with hemophagocytic syndrome. Acta Haematol. 2011;126(1):8–12.CrossRefGoogle Scholar
  46. 46.
    Jung HR, Yun SY, Choi JH, Bae SH, Ryoo HM, Kum YS. Cyclosporine in relapsed subcutaneous panniculitis-like T-cell lymphoma after autologous hematopoietic stem cell transplantation. Cancer Res Treat. 2011;43(4):255–9.CrossRefGoogle Scholar
  47. 47.
    Shen G, Dong L, Zhang S. Subcutaneous panniculitis-like T cell lymphoma mimicking early-onset nodular panniculitis. Am J Case Rep. 2016;17:429–33.CrossRefGoogle Scholar
  48. 48.
    Miura T, Kawakami Y, Sato M, Ohtsuka M, Yamamoto T. Hemophagocytic syndrome occurred in a patient with subcutaneous panniculitis-like T-cell lymphoma without overt skin lesion: successful treatment with steroid pulse therapy. J Dermatol. 2011;38(11):1113–5.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Hematology 2018

Authors and Affiliations

  • Ting-An Lin
    • 1
  • Ching-Fen Yang
    • 2
    • 3
  • Yao-Chung Liu
    • 1
    • 3
  • Jin-Hwang Liu
    • 1
    • 3
  • Tzeon-jye Chiou
    • 3
    • 4
  • Liang-Tsai Hsiao
    • 1
    • 3
  • Hsiu-Ju Yen
    • 3
    • 5
  • Chia-Jen Liu
    • 1
    • 3
  • Hao-Yuan Wang
    • 1
    • 3
  • Po-Shen Ko
    • 1
    • 3
  • Sheng-Hsuan Chien
    • 3
    • 4
  • Jyh-Pyng Gau
    • 1
    • 3
    Email author
  1. 1.Division of Hematology, Department of MedicineTaipei Veterans General HospitalTaipeiTaiwan
  2. 2.Department of Pathology and Laboratory MedicineTaipei Veterans General HospitalTaipeiTaiwan
  3. 3.Faculty of MedicineNational Yang-Ming UniversityTaipeiTaiwan
  4. 4.Division of Transfusion Medicine, Department of MedicineTaipei Veterans General HospitalTaipeiTaiwan
  5. 5.Department of PediatricsTaipei Veterans General HospitalTaipeiTaiwan

Personalised recommendations